Nature’s Miracle (NMHI) president and director Zhiyi Zhang steps down

Rhea-AI Filing Summary

Nature’s Miracle Holding Inc. reports a leadership change. Zhiyi (Jonathan) Zhang resigned as President of the company effective February 28, 2026, and stepped down from the board of directors and its committees effective December 31, 2025. The company states his resignation was not due to any disagreement over operations, policies, or practices. The board has appointed Jinlong (Frank) Du to Zhang’s former roles, consistent with a prior disclosure made on February 9, 2026.

Insights

Corporate governance analyst

Key executive and director exits, but with a named successor and no stated disputes.

The company discloses that Zhiyi (Jonathan) Zhang has resigned as President and as a board and committee member, with his board departure effective December 31, 2025 and his officer role ending February 28, 2026. Leadership transitions at this level can influence execution and strategic continuity.

However, the filing specifies that Zhang’s resignation was not due to any disagreement on operations, policies, or practices, which reduces concern about internal conflict. The board has already appointed Jinlong (Frank) Du to Zhang’s former positions, referencing an earlier disclosure on February 9, 2026, suggesting a planned handover rather than a sudden vacancy.

Future company filings may provide more detail on Du’s impact in these roles and whether the transition affects strategic priorities or performance metrics, but this excerpt focuses on the fact of the change and the absence of reported disputes.

false 0001947861 0001947861 2025-12-31 2025-12-31 0001947861 NMHI:CommonStockParValue0.0001PerShareMember 2025-12-31 2025-12-31 0001947861 NMHI:WarrantsToPurchaseCommonStockAtExercisePriceOf11.50PerShareMember 2025-12-31 2025-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 31, 2025

NATURE’S MIRACLE HOLDING INC.

(Exact name of registrant as specified in its charter)

Delaware		001-41977		88-3986430
(State or other jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification Number)

3281 E. Guasti Road, Suite 175 Ontario, CA 91761		91761
(Address of registrant’s principal executive office)		(Zip code)

(909) 218-4601

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act:

Title for each class		Trading Symbol(s)
Common Stock, par value $0.0001 per share		NMHI
Warrants to purchase Common Stock, at an exercise price of $11.50 per share		NMHIW

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers

On February 28, 2026, Zhiyi (Jonathan) Zhang notified Nature’s Miracle Holdings, Inc. (the “Company”) of his decision to resign from his position as President of the Company, effective as of such date, and from the board of directors of the Company (the “Board”) and the committees thereof, effective as of December 31, 2025. In connection with Mr. Zhang’s departure from the Company, Jinlong (Frank) Du has been appointed by the Board to Mr. Zhang’s former positions, as previously disclosed in the Company’s current report on Form 8-K filed on February 9, 2026. Mr. Zhang’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

1

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
104		Cover Page Interactive Data File (formatted in Inline XBRL).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: March 13, 2026

NATURE’S MIRACLE HOLDING INC.
By:	/s/ Tie (James) Li
Name:	Tie (James) Li
Title:	Chief Executive Officer

3

FAQ

What executive change did Nature’s Miracle (NMHI) disclose in this 8-K?

Nature’s Miracle disclosed that Zhiyi (Jonathan) Zhang resigned as President effective February 28, 2026, and from the board and its committees effective December 31, 2025. The company also noted the board has appointed Jinlong (Frank) Du to Zhang’s former positions.

Was there any disagreement behind Zhiyi Zhang’s resignation from NMHI?

The company states that Zhiyi (Jonathan) Zhang’s resignation was not due to any disagreement with Nature’s Miracle on operations, policies, or practices. This language is intended to reassure investors that his departure was not triggered by internal disputes or governance conflicts.

Who is replacing Zhiyi Zhang at Nature’s Miracle (NMHI)?

The board appointed Jinlong (Frank) Du to assume Zhiyi (Jonathan) Zhang’s former positions. The filing notes this appointment had been previously disclosed on February 9, 2026, suggesting a planned leadership transition rather than a sudden, unanticipated vacancy in senior management.

What roles did Zhiyi Zhang hold at Nature’s Miracle before resigning?

Zhiyi (Jonathan) Zhang served as President of Nature’s Miracle and was a member of the board of directors and its committees. The 8-K explains his officer role ended February 28, 2026, while his board and committee service ended December 31, 2025.

Does this NMHI filing include any financial results or earnings data?

This 8-K centers on leadership and board changes and does not present revenue, earnings, or other operating results. Aside from a standard exhibit listing, the focus is on Zhiyi Zhang’s resignation and the appointment of Jinlong Du to his previous positions.

Filing Exhibits & Attachments

4 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 3.7 KB
• EX-101 XBRL DEFINITION FILE 26.1 KB
• EX-101 XBRL LABEL FILE 36.0 KB
• EX-101 XBRL PRESENTATION FILE 24.7 KB